Charles River Laboratories (CRL) is a Healthcare · Diagnostics & Research company listed on NYSE. Price $277.36 (-1.53%), Market cap $7.84B, 52-week low–high $134.98 ~ $226.77.
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Asse
Financial statements, price targets, institutional (13F) holdings and related news for Charles River Laboratories are updated in real time on BlackAll Trade.
Charles River Laboratories trades at $277.36 (-1.53%). Real-time quotes and charts are available on BlackAll Trade.
Charles River Laboratories has a market cap of about $7.84B.
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationall